Related content

Randomized, 8‐week, double‐blind, placebo‐controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52‐week open‐label extension trial

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 72, Iss. 2, 2018-02 ,pp. : 103-115

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms

By Gaynor Paula J.   Gopal Murali   Zheng Wei   Martinez James M.   Robinson Michael J.   Marangell Lauren B.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1849-1858

Informa Healthcare

Access to resources Recommend Favorite

Effect of ceralifimod (ONO‐4641) on lymphocytes and cardiac function: Randomized, double‐blind, placebo‐controlled trial with an open‐label fingolimod arm

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 1051-1060

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 72, Iss. 2, 2018-02 ,pp. : 64-72

John Wiley & Sons Inc

Access to resources Recommend Favorite

PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED TRIAL

By  

DEPRESSION AND ANXIETY (ELECTRONIC), Vol. 32, Iss. 3, 2015-03 ,pp. : 167-173

John Wiley & Sons Inc

Access to resources Recommend Favorite